Earnings Call · Q3 FY2021·2021-11-15

Q3 21EPS -1.50%·Rev n/aQ2 21EPS -7.34%·Rev n/aQ1 21EPS +6.40%·Rev n/aQ4 20EPS -0.73%·Rev n/a⚠ consensus missing

UroGen Pharma Ltd. URGN

Lee Roth — Investor Relations

Liz Barrett — Chief Executive Officer

Mark Schoenberg — Chief Medical Officer

Jeff Bova — Head of Commercial

Molly Henderson — Chief Financial Officer

−22.9%1d on move date−23.0% vs SPY3d−31.7%5d−37.0%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more URGN calls or request research access.

More URGN calls Browse calls Request research access